Literature DB >> 31518967

Superior skin cancer classification by the combination of human and artificial intelligence.

Achim Hekler1, Jochen S Utikal2, Alexander H Enk3, Axel Hauschild4, Michael Weichenthal4, Roman C Maron1, Carola Berking5, Sebastian Haferkamp6, Joachim Klode7, Dirk Schadendorf7, Bastian Schilling8, Tim Holland-Letz9, Benjamin Izar10, Christof von Kalle1, Stefan Fröhling1, Titus J Brinker11.   

Abstract

BACKGROUND: In recent studies, convolutional neural networks (CNNs) outperformed dermatologists in distinguishing dermoscopic images of melanoma and nevi. In these studies, dermatologists and artificial intelligence were considered as opponents. However, the combination of classifiers frequently yields superior results, both in machine learning and among humans. In this study, we investigated the potential benefit of combining human and artificial intelligence for skin cancer classification.
METHODS: Using 11,444 dermoscopic images, which were divided into five diagnostic categories, novel deep learning techniques were used to train a single CNN. Then, both 112 dermatologists of 13 German university hospitals and the trained CNN independently classified a set of 300 biopsy-verified skin lesions into those five classes. Taking into account the certainty of the decisions, the two independently determined diagnoses were combined to a new classifier with the help of a gradient boosting method. The primary end-point of the study was the correct classification of the images into five designated categories, whereas the secondary end-point was the correct classification of lesions as either benign or malignant (binary classification).
FINDINGS: Regarding the multiclass task, the combination of man and machine achieved an accuracy of 82.95%. This was 1.36% higher than the best of the two individual classifiers (81.59% achieved by the CNN). Owing to the class imbalance in the binary problem, sensitivity, but not accuracy, was examined and demonstrated to be superior (89%) to the best individual classifier (CNN with 86.1%). The specificity in the combined classifier decreased from 89.2% to 84%. However, at an equal sensitivity of 89%, the CNN achieved a specificity of only 81.5%
INTERPRETATION: Our findings indicate that the combination of human and artificial intelligence achieves superior results over the independent results of both of these systems.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Artificial intelligence; Deep learning; Melanoma; Skin cancer

Mesh:

Year:  2019        PMID: 31518967     DOI: 10.1016/j.ejca.2019.07.019

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  18 in total

1.  InSiNet: a deep convolutional approach to skin cancer detection and segmentation.

Authors:  Hatice Catal Reis; Veysel Turk; Kourosh Khoshelham; Serhat Kaya
Journal:  Med Biol Eng Comput       Date:  2022-01-13       Impact factor: 2.602

2.  The potential of using artificial intelligence to improve skin cancer diagnoses in Hawai'i's multiethnic population.

Authors:  Mark Lee Willingham; Shane Y P K Spencer; Christopher A Lum; Janira M Navarro Sanchez; Terrilea Burnett; John Shepherd; Kevin Cassel
Journal:  Melanoma Res       Date:  2021-12-01       Impact factor: 3.599

Review 3.  Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms: A Scoping Review.

Authors:  Roxana Daneshjou; Mary P Smith; Mary D Sun; Veronica Rotemberg; James Zou
Journal:  JAMA Dermatol       Date:  2021-11-01       Impact factor: 11.816

4.  Improving Crowdsourcing-Based Image Classification Through Expanded Input Elicitation and Machine Learning.

Authors:  Romena Yasmin; Md Mahmudulla Hassan; Joshua T Grassel; Harika Bhogaraju; Adolfo R Escobedo; Olac Fuentes
Journal:  Front Artif Intell       Date:  2022-06-29

Review 5.  The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World.

Authors:  Claire M Felmingham; Nikki R Adler; Zongyuan Ge; Rachael L Morton; Monika Janda; Victoria J Mar
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 7.403

6.  Medical Professional Enhancement Using Explainable Artificial Intelligence in Fetal Cardiac Ultrasound Screening.

Authors:  Akira Sakai; Masaaki Komatsu; Reina Komatsu; Ryu Matsuoka; Suguru Yasutomi; Ai Dozen; Kanto Shozu; Tatsuya Arakaki; Hidenori Machino; Ken Asada; Syuzo Kaneko; Akihiko Sekizawa; Ryuji Hamamoto
Journal:  Biomedicines       Date:  2022-02-25

Review 7.  Machine Learning in Dermatology: Current Applications, Opportunities, and Limitations.

Authors:  Stephanie Chan; Vidhatha Reddy; Bridget Myers; Quinn Thibodeaux; Nicholas Brownstone; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2020-04-06

8.  Studying human-AI collaboration protocols: the case of the Kasparov's law in radiological double reading.

Authors:  Federico Cabitza; Andrea Campagner; Luca Maria Sconfienza
Journal:  Health Inf Sci Syst       Date:  2021-02-05

Review 9.  Artificial Intelligence Applications to Improve the Treatment of Locally Advanced Non-Small Cell Lung Cancers.

Authors:  Andrew Hope; Maikel Verduin; Thomas J Dilling; Ananya Choudhury; Rianne Fijten; Leonard Wee; Hugo Jwl Aerts; Issam El Naqa; Ross Mitchell; Marc Vooijs; Andre Dekker; Dirk de Ruysscher; Alberto Traverso
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

10.  Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study.

Authors:  Titus J Brinker; Roman C Maron; Jochen S Utikal; Achim Hekler; Axel Hauschild; Elke Sattler; Wiebke Sondermann; Sebastian Haferkamp; Bastian Schilling; Markus V Heppt; Philipp Jansen; Markus Reinholz; Cindy Franklin; Laurenz Schmitt; Daniela Hartmann; Eva Krieghoff-Henning; Max Schmitt; Michael Weichenthal; Christof von Kalle; Stefan Fröhling
Journal:  J Med Internet Res       Date:  2020-09-11       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.